Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by NB1017on Oct 25, 2018 4:51pm
181 Views
Post# 28874221

RE:RE:Time to Buy

RE:RE:Time to BuyThe American Investors haven't quite caught on yet that Aurora has a major advantage within the Medicinal MJ sector, but once they do, there will be no holding back... US$20 without a major deal announcement, US$40 with a deal secured.
longonMJ wrote: Well, they did released good news today in the form of being the first private company to receive approval to export into Poland.

Unfortunately, this didn't seem to help the stock price at all, as Aurora had a much smaller percentage gain today than virtually ALL of the weed stocks in the marketplace.

MJ MadeMeRich wrote:
You buy on weakness, now is the time to buy. ACB came back all the way down to $9 range. It should easily be $10+ with no news.

If any good news gets released (eg. Coke) than $15 is the Target price.





Bullboard Posts